From Innovation to Regulation: Securing AI Governance Strategy in MedTech

LIBERTYVILLE, Ill. - Aug. 12, 2025 - PRLog -- Compliance Group Inc. is excited to present Part 2 of its impactful webinar series, "AI Governance Strategic Imperative in MedTech," titled "Regulatory Perspective (FDA Focus)."

Scheduled for Tuesday, August 27, 2025, from 11:00–11:45 AM EST, this live virtual session will focus on how medical device and pharmaceutical companies can align their AI strategy with evolving FDA expectations.

Following the expansion of Part 1, which addressed the Industry Perspective on building auditable, scalable AI governance frameworks, Part 2 brings forward expert voices with direct insights into regulatory frameworks and compliance readiness.

Featured Speakers:

• Paul Sumner, MedTech Senior Executive Thought Leader & Advisor
• Daniel Walter, Policy Analyst, U.S. Food and Drug Administration (invited)
• Sarada Ramamoorthy – Head, Strategic Consultant, Compliance Group Inc.

Moderator:

• Khaled Moussally, Executive Vice President, Corporate Development & Operations, Compliance Group Inc.

Key Takeaways:

• Deep dive into the FDA's current and emerging expectations for AI/ML-based technologies in MedTech
• Guidance on preparing audit-ready documentation and validation frameworks
• Strategies for embedding sustainable governance into your AI development lifecycle

Who Should Attend:
This session is designed for professionals in:

• Regulatory Affairs
• Quality, Compliance & Validation
• R&D and Product Development
• IT, Lifecycle Management, and Risk Strategy

This is a unique opportunity to gain clarity on regulatory pathways and position your organization for success in a future shaped by AI.

Registration is now open. Don't miss the chance to gain actionable insights and stay ahead of the regulatory curve.
https://www.complianceg.com/compliance-webinars/ai-govern...